Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's epithelium
about
Treatment for Barrett's oesophagusEfficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysisCurrent endoscopic methods of radical therapy in early esophageal cancerSecular trends in patients diagnosed with Barrett's esophagus.Argon plasma coagulation therapy for ablation of Barrett's oesophagus5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trialA randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results.High recurrence rate of Barrett's epithelium during long-term follow-up after argon plasma coagulation.Diode laser treatment of Barrett's esophagus: long-term results.Medical and endoscopic management of high-grade dysplasia in Barrett's esophagusContinuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.Long-term follow-up after complete ablation of Barrett's esophagus with argon plasma coagulation.Pharmacotherapy for chronic gastro-oesophageal reflux disease and Barrett's oesophagus.Barrett's oesophagus: the new endoscopic modalities have a future.Endoscopic therapy for Barrett's oesophagus.Photodynamic therapy for Barrett's esophagus with high-grade dysplasia.Endoprevention of esophageal cancer: endoscopic ablation of Barrett's metaplasia and dysplasia.Argon plasma coagulation for superficial esophageal squamous-cell carcinoma in high-risk patientsCleavage of E-Cadherin Contributes to Defective Barrier Function in Neosquamous Epithelium.Optimal endoluminal treatment of Barrett's esophagus: integrating novel strategies into clinical practice.New endoscopic and surgical treatment options for early esophageal adenocarcinoma.Endoscopic therapy for Barrett's esophagus: a review of its emerging role in optimal diagnosis and endoluminal therapy.Ablation of Barrett's oesophagus: towards improved outcomes for oesophageal cancer?Molecular biomarkers and ablative therapies for Barrett's esophagus.Barrett's esophagus: endoscopic treatments II.MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.Endoscopic therapy of Barrett's: what more do we need to know?A trial of radiofrequency ablation for anal intraepithelial neoplasia.Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus.Brief report: the length of newly diagnosed Barrett's esophagus may be decreasing.REG Ialpha protein expression in Barrett's esophagus.Predictors for squamous re-epithelialization of Barrett's esophagus after endoscopic biopsy.
P2860
Q24240701-203A1533-7DFB-440B-B6E1-F4FE058FE338Q26821767-1902ACCE-1E6B-4ADA-BB61-9E53C5A7FE64Q26860714-F3AC758D-AD54-4040-A4CB-478B791501D4Q30484275-B87801F5-34B0-4375-82AE-C6C8B06008FBQ30870050-8C5BF8DD-1756-49A8-94B5-3F5B93CAA816Q33202826-C474F464-B8B3-49C0-9B94-00FB6143A498Q33253758-20348893-7A86-48AB-B0CF-DE636B7CE8F7Q33267689-31AE60F8-4D38-48B5-BA1E-7EDB517AE298Q33686067-0D94BF09-816D-4F9F-97AC-9E6C4172F260Q34050233-261D1DF4-534E-4530-B292-4168073B48D5Q34504547-E117385C-B47A-4E12-9222-889B99C8B825Q34605277-98670587-2C6E-482B-9254-6C269EF56D3FQ35164691-E4EE7211-9765-44B0-BD09-866E11B6631AQ36041664-6DCD2DF2-1267-439D-B77B-807197CAF01EQ36124437-DBC58194-54EC-4672-9328-5642725F7D6CQ36131795-ED6A6ECE-FC78-4CA4-A821-774EB431CC71Q36315178-EDD5A54A-647F-4846-A6CE-60F9D5634613Q36316711-86523519-A5AC-4F5F-9D9F-2447C34452E9Q37622690-E3FBE0D6-F132-4FBB-8122-BDC0161E7F9EQ37763082-96558C4F-7D64-44A9-BD05-30256B90C602Q37783343-5D8F2B27-992F-40E8-A517-DD4DDA2A0DF9Q37967405-BF4EBD7B-F5DD-49C8-8B5B-2362FA7EF724Q38035457-96A87822-5B39-4CD2-8772-67EF7F5C7E21Q38051702-6792DDC0-DFD7-49D6-84F1-6364C45AFE6DQ39992700-55811845-BA9A-4B51-AAD2-7ECFBA1546CEQ41426289-14FFE685-6177-4C7F-8699-160B5F310394Q41861592-F96576ED-E510-419C-8699-FB7C0A8FC681Q46071146-D5BA8A07-49EA-4576-9CE0-CE44DC4364D7Q46424963-1C232163-7EE9-44D6-AE3C-09FF9C383437Q48318570-83A40DB8-BBF6-41F3-8A6A-81E307072C58Q53323896-D1F58123-649F-4132-AE51-E48E5AF06E3BQ53547055-DA470257-92CA-46F4-AE1C-30046646814F
P2860
Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's epithelium
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Efficacy and one year follow u ...... rrence of Barrett's epithelium
@ast
Efficacy and one year follow u ...... rrence of Barrett's epithelium
@en
type
label
Efficacy and one year follow u ...... rrence of Barrett's epithelium
@ast
Efficacy and one year follow u ...... rrence of Barrett's epithelium
@en
prefLabel
Efficacy and one year follow u ...... rrence of Barrett's epithelium
@ast
Efficacy and one year follow u ...... rrence of Barrett's epithelium
@en
P2093
P2860
P356
P1433
P1476
Efficacy and one year follow u ...... rrence of Barrett's epithelium
@en
P2093
P2860
P304
P356
10.1136/GUT.51.6.776
P407
P577
2002-12-01T00:00:00Z